Orthofix Medical (OFIX) Cash from Investing Activities (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Cash from Investing Activities data on file, last reported at -$10.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 56.1% year-over-year to -$10.5 million; the trailing twelve-month figure through Mar 2026 stood at -$38.4 million (down 63.66% YoY), and the FY2025 full-year result was -$34.6 million, down 25.45% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$10.5 million, up from -$10.9 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $17.1 million in Q1 2023 and bottomed at -$22.3 million in Q3 2023.
• A 5-year average of -$7.7 million and a median of -$7.5 million in 2022 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities soared 401.46% in 2023 and tumbled 857.8% in 2025, its largest moves.
• Tracing OFIX's Cash from Investing Activities over 5 years: stood at -$5.9 million in 2022, then plunged by 155.14% to -$15.1 million in 2023, then jumped by 92.46% to -$1.1 million in 2024, then tumbled by 857.8% to -$10.9 million in 2025, then climbed by 3.27% to -$10.5 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$10.5 million, -$10.9 million, and -$9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison